CTMX vs GILD: Which Stock is Better?
Side-by-side comparison of CytomX Therapeutics Inc and Gilead Sciences Inc in 2026
CTMX
CytomX Therapeutics Inc
$5.37
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | CTMX | GILD | Winner |
|---|---|---|---|
| Market Cap | $913.26M | $154.03B | GILD |
| P/E Ratio | 17.97 | 19.22 | CTMX |
| EPS (TTM) | $0.30 | $6.46 | GILD |
| Revenue Growth | -0.8% | 0.0% | GILD |
| Gross Margin | 100.0% | 78.7% | CTMX |
Analyze CTMX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or GILD a better investment?
Comparing CTMX and GILD: CytomX Therapeutics Inc has a market cap of $913.26M while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and GILD?
CTMX (CytomX Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or GILD?
Based on P/E ratios, CTMX trades at a lower multiple (18.0x vs 19.2x).
Which is growing faster: CTMX or GILD?
GILD has higher revenue growth at 0.0% vs -0.8% for CTMX.
Which company is more profitable: CTMX or GILD?
CytomX Therapeutics Inc (CTMX) has higher gross margins at 100.0% compared to 78.7% for GILD.
Which is the larger company: CTMX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $913.26M for CTMX.
Should I buy CTMX or GILD in 2026?
Both CTMX and GILD have investment merit. CTMX trades at $5.37 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and GILD stock?
Key differences: Market Cap ($913.26M vs $154.03B), P/E Ratio (18.0x vs 19.2x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (100.0% vs 78.7%).